News

  1. Home
  2. News
María José Alonso, elected Secretary of the Controlled Release Society

María José Alonso leads a USC project aimed at developing a new vaccine against COVID-19 based on mRNA

Developing and evaluating in preclinical studies a new vaccine based on mRNA against SARS-CoV2 capable of inducing long-term immune responses against the virus is the ultimate goal of the research project in which the laboratory led by María José Alonso participates together with the group led by Mabel Loza, both at CiMUS and FIDIS - University of Santiago de Compostela (USC). The objective of the USC laboratories is to produce a synthetic vehicle based on innocuous biomaterials, capable of transporting the mRNA into the target cells and enabling the production of the antigen in the human body.

María José Alonso, on ‘The Power List’ of the most influential researchers in the field of Biopharmaceuticals

Professor Alonso is the only Spanish scientist in this ranking published by the magazine 'The Medicine Maker'. This ranking highlights the career of the 60 most outstanding researchers worldwide in the areas of Small Molecules, Biopharmaceuticals, and Advanced Medicine

Get free access to our paper: “mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering”

Publication: Adriana M. Ledo, Ana Senra, Héctor Rilo-Álvarez, Erea Borrajo, Anxo Vidal, María J. Alonso, Marcos García-Fuentes, RNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering, Biomaterials, Vol. 247, July 2020 https://doi.org/10.1016/j.biomaterials.2020.120016. Free Access until May 26

María José Alonso, elected Secretary of the Controlled Release Society

The Controlled Release Society doubly awarded the prestigious ‘Distinguished Service Award’ and the ‘Women in Science Award’ to María José Alonso

These are new recognitions of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine, to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) and to the CRS College of Fellows.

Our latest paper, published in Drug Delivery and Translational Research: “Technological challenges in the preclinical development of an HIV nanovaccine candidate”

In the obstacle race to the market nanomedicines face multiple challenges. If you want to know how to address them, check our recent paper about “Technological challenges in the preclinical development of an HIV nanovaccine candidate”, which has been just published in the DDTR journal.

The 25th Anniversary of the Spanish-Portuguese Local Chapter of the Controlled Release Society is just there!

It will be held in Santiago de Compostela, January 22-24, 2020. We count with the participation of two past presidents of the CRS, Sandy Florence and María J. Alonso (founder of the SPLC-CRS), two CRS Board members, Steve Little and Mark Prausnitz, and representatives from all CRS European Local Chapters. An industry panel will also discuss the industry perspective on Nanomedicine. It is an amazing program with 20 invited speakers that so far has attracted the attention of 200 participants.

Targeting neurodegenerative diseases with RNA interference through the nose?

We describe how the physicochemical properties of polymeric nanocapsules have a tremendous impact in their capacity to disseminate and accumulate in the different subpopulations of immune cells in the lymph nodes.

Merry Christmas and a Happy New Year! Looking forward even greater advancements in sciences for a good health

Merry Christmas to everyone! We wish you a fabulous and full of science 2020!

25th Anniversary of the Spanish-Portuguese Local Chapter of the Controlled Release Society

Great participation! More than 120 presentations (Oral communications and posters) and close to 40 invited speakers. More than 200 attendees expected. Do not miss the 25th Anniversary of the SPLC-CRS! https://www.splc-crs.org/meeting-2020

Our latest paper, published in Nanomedicine: “Design of polymeric nanocapsules to improve their lympho-targeting capacity”

We describe how the physicochemical properties of polymeric nanocapsules have a tremendous impact in their capacity to disseminate and accumulate in the different subpopulations of immune cells in the lymph nodes.